0 XP   0   0   0

Palisade Bio Inc
Buy or Sell?

I guess you are interested in Palisade Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Palisade Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Palisade Bio Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Palisade Bio Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Palisade Bio Inc. The closing price on 2022-09-23 was $0.1141 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of Palisade Bio Inc
Palisade Bio Inc Daily Candlestick Chart

1.1. Profitability of Palisade Bio Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Palisade Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-46,113.2%+46,113.2%
TTM-5Y-40,844.9%+40,844.9%
5Y-40,844.9%10Y-102,774.7%+61,929.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--242.4%+242.4%
TTM--275.9%+275.9%
YOY-46,113.2%-328.0%-45,785.2%
5Y-40,844.9%-464.6%-40,380.3%
10Y-102,774.7%-547.1%-102,227.6%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of Palisade Bio Inc:

  • The MRQ is -30.0%. Very bad. -2
  • The TTM is -9.0%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-30.0%TTM-9.0%-21.0%
TTM-9.0%YOY-63.4%+54.4%
TTM-9.0%5Y-30.3%+21.3%
5Y-30.3%10Y-30.0%-0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.0%-9.8%-20.2%
TTM-9.0%-8.8%-0.2%
YOY-63.4%-9.2%-54.2%
5Y-30.3%-11.6%-18.7%
10Y-30.0%-12.7%-17.3%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of Palisade Bio Inc:

  • The MRQ is -55.7%. Very bad. -2
  • The TTM is 13.4%. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
MRQ-55.7%TTM13.4%-69.1%
TTM13.4%YOY-11.5%+25.0%
TTM13.4%5Y-4.2%+17.7%
5Y-4.2%10Y-2.1%-2.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-55.7%-11.9%-43.8%
TTM13.4%-11.2%+24.6%
YOY-11.5%-10.6%-0.9%
5Y-4.2%-13.7%+9.5%
10Y-2.1%-14.5%+12.4%

1.2. Operating Efficiency of Palisade Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Palisade Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-46,331.3%+46,331.3%
TTM-5Y-44,728.0%+44,728.0%
5Y-44,728.0%10Y-88,884.5%+44,156.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM--269.6%+269.6%
YOY-46,331.3%-306.8%-46,024.5%
5Y-44,728.0%-461.8%-44,266.2%
10Y-88,884.5%-546.8%-88,337.7%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Palisade Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY893.425-893.425
TTM-5Y538.409-538.409
5Y538.40910Y933.754-395.345
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM-3.662-3.662
YOY893.4253.692+889.733
5Y538.4095.743+532.666
10Y933.7546.919+926.835

1.3. Liquidity of Palisade Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Palisade Bio Inc:

  • The MRQ is 2.593. Good. +1
  • The TTM is 4.373. Very Good. +2
Trends
Current periodCompared to+/- 
MRQ2.593TTM4.373-1.780
TTM4.373YOY7.857-3.484
TTM4.3735Y7.155-2.782
5Y7.15510Y5.543+1.612
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5935.318-2.725
TTM4.3736.219-1.846
YOY7.8576.366+1.491
5Y7.1556.760+0.395
10Y5.5436.520-0.977
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Palisade Bio Inc:

  • The MRQ is 1.748. Very good. +2
  • The TTM is 3.623. Very good. +2
Trends
Current periodCompared to+/- 
MRQ1.748TTM3.623-1.875
TTM3.623YOY6.432-2.809
TTM3.6235Y4.212-0.589
5Y4.21210Y2.704+1.508
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7484.101-2.353
TTM3.6234.994-1.371
YOY6.4325.256+1.176
5Y4.2125.338-1.126
10Y2.7045.050-2.346

1.4. Solvency of Palisade Bio Inc.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of Palisade Bio Inc:

  • The MRQ is 0.461. Very good. +2
  • The TTM is 0.514. Healty. +1
Trends
Current periodCompared to+/- 
MRQ0.461TTM0.514-0.054
TTM0.514YOY0.523-0.008
TTM0.5145Y0.380+0.134
5Y0.38010Y0.465-0.085
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4610.269+0.192
TTM0.5140.267+0.247
YOY0.5230.297+0.226
5Y0.3800.362+0.018
10Y0.4650.398+0.067
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of Palisade Bio Inc:

  • The MRQ is 0.854. Very good. +2
  • The TTM is 1.362. Healty. +1
Trends
Current periodCompared to+/- 
MRQ0.854TTM1.362-0.508
TTM1.362YOY0.141+1.221
TTM1.3625Y0.326+1.035
5Y0.32610Y0.159+0.167
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8540.305+0.549
TTM1.3620.303+1.059
YOY0.1410.309-0.168
5Y0.3260.382-0.056
10Y0.1590.436-0.277

2. Market Valuation of Palisade Bio Inc

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Palisade Bio Inc:

  • The EOD is 0.835. Very good. +2
  • The MRQ is 3.000. Very good. +2
  • The TTM is 0.385. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.835MRQ3.000-2.165
MRQ3.000TTM0.385+2.615
TTM0.385YOY-0.245+0.630
TTM0.3855Y0.029+0.355
5Y0.02910Y0.014+0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.835-2.088+2.923
MRQ3.000-2.275+5.275
TTM0.385-3.793+4.178
YOY-0.245-4.994+4.749
5Y0.029-3.642+3.671
10Y0.014-3.303+3.317
2.2. Price/Earnings-to-Growth Ratio

Let's take a look of the Price/Earnings-to-Growth Ratio trends of Palisade Bio Inc:

  • The MRQ is -0.029. Very Bad. -2
  • The TTM is -0.008. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.029TTM-0.008-0.021
TTM-0.008YOY0.206-0.214
TTM-0.0085Y0.034-0.043
5Y0.03410Y0.0340.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0290.005-0.034
TTM-0.0080.020-0.028
YOY0.2060.041+0.165
5Y0.0340.021+0.013
10Y0.0340.017+0.017

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Palisade Bio Inc:

  • The EOD is 0.550. Very good. +2
  • The MRQ is 1.976. Good. +1
  • The TTM is 3.972. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD0.550MRQ1.976-1.426
MRQ1.976TTM3.972-1.996
TTM3.972YOY-0.968+4.939
TTM3.9725Y0.632+3.339
5Y0.63210Y0.308+0.324
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5501.808-1.258
MRQ1.9761.944+0.032
TTM3.9722.750+1.222
YOY-0.9683.490-4.458
5Y0.6322.731-2.099
10Y0.3082.401-2.093

2.4. Latest News of Palisade Bio Inc

Does Palisade Bio Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Palisade Bio Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-23
22:30
Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Read

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Palisade Bio Inc.

3.1. Institutions holding Palisade Bio Inc

Institutions are holding 1.374% of the shares of Palisade Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31Vanguard Group Inc1.241302716042801411.5005
2022-06-30Sargent Investment Group, LLC1.09690.030324000011000084.6154
2022-03-31Geode Capital Management, LLC0.58010126936-81627-39.1378
2022-03-31Citadel Advisors Llc0.3192069842698420
2022-06-30Strategic Wealth Designers0.24280.00555312900
2022-03-31JANE STREET GROUP, LLC0.16560362231393862.5443
2022-03-31TWO SIGMA SECURITIES, LLC0.15620.00133417719684135.8173
2022-06-30Private Advisor Group, LLC0.15310.000133500335000
2022-03-31State Street Corporation0.128902821000
2022-03-31Northern Trust Corp0.10602318600
2022-03-31Two Sigma Investments LLC0.09850.000121560708348.9259
2022-03-31Renaissance Technologies Corp0.0973021300-59835-73.7475
2022-06-30First American Trust Co0.09320.001320392203920
2022-03-31Wells Fargo & Co0.074501630410004158.7937
2022-03-31UBS Group AG0.0371081094275111.5023
2022-03-31Morgan Stanley - Brokerage Accounts0.0320700900
2022-03-31Tower Research Capital LLC0.02370.00015178390.7589
2022-03-31Advisor Group Holdings, Inc.0.01870410041000
2022-03-31JPMorgan Chase & Co0.004509839830
2022-03-31Northwestern Mutual Wealth Management Co0.000306200
Total 4.66990.03871021804  

3.2. Funds holding Palisade Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31Vanguard Total Stock Mkt Idx Inv0.8977019641500
2022-07-31Vanguard Extended Market Index Investor0.317206941000
2022-06-30Fidelity® NASDAQ Composite Index®0.29860.00036533700
2022-06-30Fidelity® Extended Market Index0.28080.00016143100
2022-06-30Foord Global Equity (Lux) A0.1660.003736332-10000-21.5834
2022-06-30Foord Global Equity Class B0.14320.003631332-10000-24.1943
2022-06-30Northern Trust Extended Eq Market Idx0.0610.00011334900
2022-06-30NT Ext Equity Mkt Idx Fd - L0.0610.00011334900
2022-06-30NT Ext Equity Mkt Idx Fd - NL0.04310.0001943600
2022-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.03430.000175074816.846
2022-07-31Vanguard U.S. Eq Idx £ Acc0.02640577900
2022-06-30Spartan Total Market Index Pool E0.01410308130810
2022-06-30NT US Market Cap Idx Fd - L0.0018040000
2022-06-30Northern Trust Wilshire 50000.0018040000
2022-06-30Spartan Extended Market Index Pool E0.0008016800
2022-06-30BlackRock Extended Mkt Composite0.0004092920
2022-06-30BlackRock Extended Equity Market K0.000408200
2022-07-31State St US Extended Mkt Indx NL Cl C0.000101700
2022-06-30SSgA U.S. Extended Market Index Class I0.000101700
2022-07-29iShares Core S&P Total US Stock Mkt ETF0.000101600
Total 2.34890.0081513950  

3.3. Insider Transactions

Insiders are holding 7.716% of the shares of Palisade Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-23John David FinleyBUY73500.16129246
2022-08-16John David FinleyBUY1000000.25121896
2022-08-16Thomas HallamBUY400000.2557592
2022-03-29Michael John DawsonBUY150001.14
2022-03-28Thomas HallamBUY100001.18
2022-03-24John David FinleyBUY75001.09
2021-09-21John David FinleyBUY20002.44
2021-09-21Thomas HallamBUY60002.49
2021-09-09Robert J TrenschelBUY34002.891750
2021-09-07Robert J TrenschelBUY27072.78
2021-08-31Robert J. TrenschelBUY17502.751750
2021-08-27John David FinleyBUY100002.65

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Palisade Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.2070.359-42%0.189+10%3.240-94%17.158-99%
Current Ratio--2.5934.373-41%7.857-67%7.155-64%5.543-53%
Debt To Asset Ratio--0.4610.514-10%0.523-12%0.380+21%0.465-1%
Debt To Equity Ratio--0.8541.362-37%0.141+506%0.326+162%0.159+437%
Eps---0.1150.034-438%-1.036+797%-5.158+4366%-12.597+10807%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-461.1320%-408.4490%-1027.7470%
Operating Margin----0%-463.3130%-447.2800%-888.8450%
Operating Ratio----0%893.425-100%538.409-100%933.754-100%
Pb Ratio0.550-259%1.9763.972-50%-0.968+149%0.632+212%0.308+541%
Pe Ratio0.835-259%3.0000.385+680%-0.245+108%0.029+10129%0.014+20896%
Peg Ratio---0.029-0.008-71%0.206-114%0.034-185%0.034-185%
Price Per Share0.114-259%0.4101.355-70%1.018-60%0.499-18%0.243+68%
Quick Ratio--1.7483.623-52%6.432-73%4.212-58%2.704-35%
Return On Assets---0.300-0.090-70%-0.634+111%-0.303+1%-0.300+0%
Return On Equity---0.5570.134-514%-0.115-79%-0.042-92%-0.021-96%
 EOD+3 -0MRQTTM+5 -7YOY+7 -65Y+5 -810Y+5 -8

4.2. Fundamental Score

Let's check the fundamental score of Palisade Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.835
Price to Book Ratio (EOD)Between0-10.550
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.748
Current Ratio (MRQ)Greater than12.593
Debt To Asset Ratio (MRQ)Less than10.461
Debt to Equity Ratio (MRQ)Less than10.854
Return On Equity (MRQ)Greater than0.15-0.557
Return on Assets (MRQ)Greater than0.05-0.300
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Palisade Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.684
Ma 20Greater thanMa 500.148
Ma 50Greater thanMa 1000.267
Ma 100Greater thanMa 2000.384
OpenGreater thanClose0.110
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets7,806
Total Liabilities3,595
Total Stockholder Equity4,211
 As reported
Total Liabilities 3,595
Total Stockholder Equity+ 4,211
Total Assets = 7,806

Assets

Total Assets7,806
Total Current Assets7,415
Long-term Assets7,415
Total Current Assets
Cash And Cash Equivalents 4,980
Net Receivables 20
Other Current Assets 2,435
Total Current Assets  (as reported)7,415
Total Current Assets  (calculated)7,435
+/- 20
Long-term Assets
Property Plant Equipment 365
Other Assets 26
Long-term Assets  (as reported)391
Long-term Assets  (calculated)391
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,860
Long-term Liabilities735
Total Stockholder Equity4,211
Total Current Liabilities
Short-term Debt 709
Short Long Term Debt 611
Accounts payable 1,041
Other Current Liabilities 1,110
Total Current Liabilities  (as reported)2,860
Total Current Liabilities  (calculated)3,471
+/- 611
Long-term Liabilities
Capital Lease Obligations 364
Other Liabilities 469
Long-term Liabilities  (as reported)735
Long-term Liabilities  (calculated)833
+/- 98
Total Stockholder Equity
Common Stock220
Retained Earnings -101,191
Other Stockholders Equity 105,182
Total Stockholder Equity (as reported)4,211
Total Stockholder Equity (calculated)4,211
+/-0
Other
Capital Stock222
Cash and Short Term Investments 4,980
Common Stock Shares Outstanding 20,295
Liabilities and Stockholders Equity 7,806
Net Debt -4,005
Net Invested Capital 4,820
Net Tangible Assets 4,209
Net Working Capital 4,555
Short Long Term Debt Total 975



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-09-302006-06-30
> Total Assets 
3,290
2,610
1,933
5,865
5,638
7,826
8,697
7,399
5,851
5,469
4,123
3,732
3,052
3,007
8,218
14,905
12,544
10,591
9,710
7,420
5,889
4,086
6,846
3,957
11,242
8,750
15,411
13,798
19,166
19,414
35,924
32,629
29,443
29,844
30,799
26,372
21,142
15,048
10,199
13,295
8,451
22,604
18,728
13,268
16,189
13,884
9,233
7,721
7,684
5,406
3,522
8,944
6,584
11,361
17,102
15,170
12,892
8,763
14,949
16,274
12,512
8,350
7,806
7,8068,35012,51216,27414,9498,76312,89215,17017,10211,3616,5848,9443,5225,4067,6847,7219,23313,88416,18913,26818,72822,6048,45113,29510,19915,04821,14226,37230,79929,84429,44332,62935,92419,41419,16613,79815,4118,75011,2423,9576,8464,0865,8897,4209,71010,59112,54414,9058,2183,0073,0523,7324,1235,4695,8517,3998,6977,8265,6385,8651,9332,6103,290
   > Total Current Assets 
3,218
2,524
1,846
5,724
5,485
7,534
8,382
7,047
5,462
5,040
3,667
3,279
2,581
2,453
7,647
14,298
11,891
9,830
8,739
6,449
4,849
3,017
5,783
2,831
10,164
7,653
13,542
11,971
17,329
17,619
34,109
30,842
27,734
28,162
29,153
24,726
19,564
13,521
8,738
11,840
6,687
20,905
17,172
11,687
14,707
12,449
7,915
6,506
6,508
4,538
2,708
7,966
5,647
10,464
16,242
14,991
12,881
8,756
14,725
16,092
12,374
8,258
7,415
7,4158,25812,37416,09214,7258,75612,88114,99116,24210,4645,6477,9662,7084,5386,5086,5067,91512,44914,70711,68717,17220,9056,68711,8408,73813,52119,56424,72629,15328,16227,73430,84234,10917,61917,32911,97113,5427,65310,1642,8315,7833,0174,8496,4498,7399,83011,89114,2987,6472,4532,5813,2793,6675,0405,4627,0478,3827,5345,4855,7241,8462,5243,218
       Cash And Cash Equivalents 
3,203
2,486
1,807
5,699
5,346
7,404
8,258
6,967
5,250
4,903
3,567
3,218
2,421
2,310
7,515
14,026
11,589
9,261
8,546
6,142
4,195
2,352
5,144
2,540
9,873
7,444
12,659
11,166
16,402
16,846
18,343
15,232
11,945
12,519
13,593
8,649
13,131
4,717
7,621
11,129
5,676
15,195
11,680
6,442
9,064
6,675
7,093
5,737
5,787
4,005
2,281
7,300
5,115
10,030
15,835
12,652
10,529
6,561
12,653
14,104
10,495
6,644
4,980
4,9806,64410,49514,10412,6536,56110,52912,65215,83510,0305,1157,3002,2814,0055,7875,7377,0936,6759,0646,44211,68015,1955,67611,1297,6214,71713,1318,64913,59312,51911,94515,23218,34316,84616,40211,16612,6597,4449,8732,5405,1442,3524,1956,1428,5469,26111,58914,0267,5152,3102,4213,2183,5674,9035,2506,9678,2587,4045,3465,6991,8072,4863,203
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,000
15,000
15,007
15,007
15,032
15,032
5,017
7,517
7,517
0
0
5,000
5,000
5,000
5,000
5,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000005,0005,0005,0005,0005,000007,5177,5175,01715,03215,03215,00715,00715,00015,000000000000000000000000000000000
       Net Receivables 
0
0
79
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
234
57
1
3
104
57
8
10
11
24
33
226
8
19
19
37
39
5
64
64
15
5
95
372
479
224
358
238
170
61
21
19
17
9
59
25
59
116
150
86
20
2086150116592559917192161170238358224479372955156464539371919822633241110857104315723400000000000000000047900
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,331
2,352
2,195
2,013
1,872
1,879
1,528
2,435
2,4351,5281,8791,8722,0132,1952,3522,3310000000000000000000000000000000000000000000000000000000
   > Long-term Assets 
72
86
87
141
154
292
315
352
390
429
456
453
471
554
571
607
653
761
971
971
1,039
1,069
1,063
1,127
1,078
1,097
1,869
1,827
1,837
1,794
1,815
1,786
1,709
1,682
1,646
1,647
1,578
1,528
1,461
1,455
1,763
1,700
1,556
1,581
1,482
1,436
1,318
1,215
1,176
867
814
977
937
897
859
178
11
7
224
182
138
92
391
391921381822247111788598979379778148671,1761,2151,3181,4361,4821,5811,5561,7001,7631,4551,4611,5281,5781,6471,6461,6821,7091,7861,8151,7941,8371,8271,8691,0971,0781,1271,0631,0691,039971971761653607571554471453456429390352315292154141878672
       Property Plant Equipment 
52
36
33
82
87
137
155
175
172
164
156
145
136
197
202
187
163
200
232
336
312
292
266
269
246
230
208
190
254
231
310
310
301
301
282
343
336
343
337
363
316
270
243
219
196
173
128
107
90
76
63
289
420
222
205
25
11
7
198
156
112
66
365
36566112156198711252052224202896376901071281731962192432703163633373433363432823013013103102312541902082302462692662923123362322001631872021971361451561641721751551378782333652
       Intangible Assets 
14
13
18
23
24
111
111
127
163
212
239
249
264
302
320
370
440
500
537
567
658
702
721
798
772
807
877
985
1,048
1,138
1,191
1,247
1,246
1,233
1,242
1,205
1,147
1,103
1,067
1,034
984
990
905
945
915
883
814
789
764
738
713
688
669
650
631
153
147
142
0
0
0
0
0
000001421471536316506696887137387647898148839159459059909841,0341,0671,1031,1471,2051,2421,2331,2461,2471,1911,1381,0489858778077727987217026585675375004403703203022642492392121631271111112423181314
       Long-term Assets Other 
6
36
36
36
43
43
49
49
54
53
61
58
71
56
49
49
49
61
202
69
69
75
75
59
60
60
785
652
536
426
314
229
162
148
122
98
95
81
58
58
463
440
409
417
370
379
376
319
322
53
37
237
0
0
0
0
26
152
26
26
26
26
26
2626262626152260000237375332231937637937041740944046358588195981221481622293144265366527856060597575696920261494949567158615354494943433636366
> Total Liabilities 
5,366
304
380
566
880
1,017
494
936
1,271
1,265
4,393
5,138
7,976
8,023
3,195
3,922
3,928
2,737
1,034
1,154
1,986
2,426
2,312
1,469
2,143
1,777
9,718
9,385
10,899
10,995
9,027
8,600
8,539
12,125
11,437
11,833
12,239
10,081
10,368
12,458
12,236
11,274
8,949
5,575
4,624
5,369
3,058
3,242
1,635
2,134
1,559
1,901
1,458
1,383
867
1,047
3,281
1,186
24,393
12,354
5,147
3,558
3,595
3,5953,5585,14712,35424,3931,1863,2811,0478671,3831,4581,9011,5592,1341,6353,2423,0585,3694,6245,5758,94911,27412,23612,45810,36810,08112,23911,83311,43712,1258,5398,6009,02710,99510,8999,3859,7181,7772,1431,4692,3122,4261,9861,1541,0342,7373,9283,9223,1958,0237,9765,1384,3931,2651,2719364941,0178805663803045,366
   > Total Current Liabilities 
5,342
281
360
547
866
1,017
494
936
1,271
1,265
1,630
1,902
2,353
1,561
3,195
3,922
3,928
2,737
1,034
1,154
1,986
2,426
2,312
1,469
2,120
1,756
2,653
3,006
5,148
5,936
4,674
4,991
5,705
4,009
4,336
5,910
7,470
6,515
7,621
8,612
7,852
7,333
5,048
2,304
1,835
1,515
766
1,185
1,051
1,210
1,071
1,581
1,225
1,186
676
1,002
3,206
1,015
3,850
2,920
2,496
1,864
2,860
2,8601,8642,4962,9203,8501,0153,2061,0026761,1861,2251,5811,0711,2101,0511,1857661,5151,8352,3045,0487,3337,8528,6127,6216,5157,4705,9104,3364,0095,7054,9914,6745,9365,1483,0062,6531,7562,1201,4692,3122,4261,9861,1541,0342,7373,9283,9223,1951,5612,3531,9021,6301,2651,2719364941,0178665473602815,342
       Short-term Debt 
8
8
8
6
8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
511
1,236
1,986
2,763
2,850
2,952
3,058
730
1,929
3,170
4,458
4,635
4,466
5,906
4,829
3,706
2,531
0
0
0
0
0
0
0
0
400
265
126
34
0
0
0
1,325
726
199
65
709
709651997261,32500034126265400000000002,5313,7064,8295,9064,4664,6354,4583,1701,9297303,0582,9522,8502,7631,9861,23651100000000000000000000086888
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,047
0
1,141
568
87
0
611
6110875681,14101,04700000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,047
0
0
0
649
521
1,607
1,729
1,323
1,546
1,041
1,0411,5461,3231,7291,6075216490002,0470000000000000000000000000000000000000000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
425
2,557
494
918
465
974
253
1,110
1,1102539744659184942,5574250000000000000000000000000000000000000000000000000000000
   > Long-term Liabilities 
25
23
21
19
14
0
0
0
0
0
2,763
3,237
5,622
6,462
6,462
0
0
0
0
0
0
0
0
0
24
21
7,064
6,379
5,751
5,059
4,353
3,609
2,834
8,116
7,101
5,923
4,769
3,566
2,747
3,847
4,383
3,940
3,901
3,272
2,789
3,855
2,292
2,057
584
924
488
320
233
196
191
45
11,539
171
20,543
9,434
2,651
1,694
735
7351,6942,6519,43420,54317111,539451911962333204889245842,0572,2923,8552,7893,2723,9013,9404,3833,8472,7473,5664,7695,9237,1018,1162,8343,6094,3535,0595,7516,3797,06421240000000006,4626,4625,6223,2372,763000001419212325
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,830
3,620
20,526
9,434
2,651
1,694
469
4691,6942,6519,43420,5263,6201,83000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,817
2,337
0
0
0
0
0
000002,3371,81700000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,978
16,234
14,122
9,768
7,729
-9,444
3,920
7,365
4,792
4,211
4,2114,7927,3653,920-9,4447,7299,76814,12216,2349,97800000000000000000000000000000000000000000000000000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
102
94
173
173
173
29
114
130
143
183
220
22018314313011429173173173941020000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000-3-1-40-950-95000-902-90200-82200-725-72500-629-62900-483-48300-346-34600-424-42400-323-32300-218-21800-145-14500-90-90-40-40-40-40-1,179-1,179-1,179-797-797
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
239,440
247,568
247,775
247,836
248,228
0
0
0
0
0
00000248,228247,836247,775247,568239,44000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-7
-7
247,777
9,596
7,703
94,242
99,503
101,864
103,454
105,182
105,182103,454101,86499,50394,2427,7039,596247,777-7-700000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.